Pipeline Database
Search registered and registrable products by therapeutic area, modality, strength, GMP status and registration territory — then inquire on any row that fits your brief.
| Code | Product | Strength | Indication | GMP | Registration |
|---|---|---|---|---|---|
| UB941 | Thalidomide Tablet | 25mg, 50mg | Lepromatous leprosy reaction; Multiple myeloma | CN - NMPA | China |
| UB925 | Lenalidomide Capsule | 5mg, 10mg, 25mg | Multiple myeloma; Myelodysplastic syndrome with 5q deletion | CN - NMPA | China |
| UB921 | Capivasertib Tablet | 160mg, 200mg | Advanced solid tumour | CN - NMPA | China |
| UB919 | Venetoclax Tablet | 10mg, 50mg, 100mg | Chronic lymphocytic leukemia; Small lymphocytic lymphoma; Acute myeloid leukemia | CN - NMPA | China |
| UB917 | Darolutamide Tablet | 300mg | Non-metastatic castration-resistant prostate cancer | CN - NMPA | China |
| UB916 | Abemaciclib Tablet | 50mg, 100mg, 150mg, 200mg | HR-positive, HER2-negative advanced breast cancer; HR-positive, HER2-negative metastatic breast cancer | CN - NMPA | China |
| UB867 | Sunitinib Capsules | 12.5mg, 25mg, 37.5mg, 50mg | Gastrointestinal stromal tumor; Renal cell carcinoma; Pancreatic neuroendocrine tumor | US - FDA | United States |
| UB863 | Leuprorelin Acetate Microspheres for Injection（1 month） | 3.75mg/vial | Breast cancer; Prostate cancer; Endometriosis; Central precocious puberty | CN - NMPA | China |
| UB862 | Paclitaxel For Injection (Albumin Bound) | 100mg/vial | Metastatic breast cancer; Non-small cell lung cancer; Metastatic adenocarcinoma of the pancreas | CN - NMPA | China |
| UB859 | Irinotecan Hydrochlorid Liposome injection | 43mg/10ml | Metastatic adenocarcinoma of the pancreas | CN - NMPA; US - FDA | China |
| UB857 | Doxorubicin Hydrochloride Liposome Injection | 20mg/10ml | Breast cancer; Ovarian cancer; AIDS-related Kaposi's sarcoma; Multiple myeloma | CN - NMPA; US - FDA | China |
| UB850 | Olaparib Tablets | 100mg; 150mg | BRCA-mutated advanced ovarian cancer; BRCA-mutated advanced fallopian tube cancer; BRCA-mutated advanced primary peritoneal cancer; BRCA-mutated HER2-negative metastatic breast cancer | CN - NMPA | China |
| UB837 | Oxaliplatin for Injection | 50mg | Colon cancer stage III; Advanced colorectal cancer | CN - NMPA | China |
| UB788 | Medroxyprogesterone Acetate Tablets | / | Irregular menstruation; Dysfunctional uterine bleeding; Endometriosis; Advanced breast cancer; Endometrial cancer | PIC/S; US - FDA | China |
| UB774 | Human Granulocyte Colony-Stimulating Factor Injection | 150mcg and 300mcg/vial; 300mcg/0.5ml/PFS | Neutropenia | CN - NMPA | China |
| UB772 | Telpegfilgrastim Injection | 2mg/ml/PFS | Neutropenia | CN - NMPA | China |
| UB766 | Penpulimab Injection | 100mg（10ml）/bottle | Relapsed or refractory classical Hodgkin lymphoma; Locally advanced or metastatic squamous non-small cell lung cancer | CN - NMPA | China |
| UB765 | Lenvatinib Mesilate Capsules | 4mg; 10mg | Hepatocellular carcinoma; Differentiated thyroid cancer | CN - NMPA | China |
| UB764 | Trifluridine and Tipiracil Hydrochloride Tablets | / | Colorectal cancer metastatic | CN - NMPA | China |
| UB763 | Bevacizumab Injection | 100mg（4ml）/bottle | Metastatic colorectal cancer; Advanced-stage non-small cell lung cancer; Metastatic non-small cell lung cancer; Recurrent non-small cell lung cancer; Recurrent glioblastoma; Epithelial ovarian cancer; Fallopian tube cancer; Primary peritoneal cancer; Cervical cancer; Hepatocellular carcinoma | CN - NMPA | China |
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →